Summary
Overview
Work History
Education
Skills
Certification
Select Clinical Projects
Committee Involvement
Preceptor Experience
Awards
Select Presentations
Research
Timeline
Generic

Sloka Manvi

Euless

Summary

Critical Care/Emergency Pharmacist Specialist with expertise in scientific communication, healthcare stakeholder engagement, and clinical data interpretation. Proven ability to cultivate professional relationships with healthcare providers, develop and deliver educational presentations, and facilitate evidence-based discussions on complex disease states and therapeutic strategies. Experienced in evaluating emerging clinical research, communicating scientific insights, and collaborating across multidisciplinary teams to support informed decision-making. Passionate about advancing scientific understanding and improving patient outcomes through education, insight generation, and cross-functional collaboration.

S

Overview

20
20
years of professional experience
1
1
Certification

Work History

Medical Intensive Care/Pulmonary Clinical Pharmacist

John Peter Smith (JPS) Health Network
2013.08 - Current
  • Serve as a therapeutic area expert, providing evidence-based recommendations and translating complex clinical data into actionable treatment strategies
  • Develop and maintain relationships with Thought Leaders (TLs) and Healthcare Providers (HCPs) by engaging in collaborative research projects and providing scientific presentations, resulting in improved patient outcomes and increased access to innovative treatments
  • Provide detailed drug information requests and respond to physician related questions by interpreting the literature and applying to specific patient population
  • Actively engage in new hospital protocol development to initiate Health System wide change
  • Participate in Pharmacy and Therapeutics Committee meetings to support or reject drug formulary requests
  • Actively engage in new hospital protocol development to initiate Health System-wide change

Resident Pharmacist

Shands Jacksonville Medical Center
2011.06 - 2013.06

Drug Development Associate

Dr. Reddy Labs
Hyderabad
2006.04 - 2006.05

Education

PGY-2 Critical Care Pharmacy Residency -

University of Florida, Shands at Jacksonville Medical Center
Jacksonville, Florida
2013-06

PGY-1 Pharmacy Residency -

University of Florida, Shands at Jacksonville Medical Center
Jacksonville, Florida
2012-06

Doctor of Pharmacy -

Roseman University of Health Sciences, College of Pharmacy
Henderson, Nevada
2011-06

Bachelor of Pharmacy -

Osmania University
Hyderabad, India
2008-05

Skills

  • Protocol development
  • Clinical data interpretation
  • Therapeutic area expertise
  • evidence-based practices
  • Critical thinking
  • Effective communication

Certification

  • Registered Pharmacist, Texas, 53523, 08/01/13, present
  • Registered Pharmacist, Florida, PS47921, 07/01/11, present
  • BLS, ACLS Certifications, American Heart Association, 07/01/11, present
  • PALS, American Heart Association, 02/01/20, present

Select Clinical Projects

  • Pulmonary Arterial Hypertension Protocol/Pathway, 01/01/26, Developed an evidence-based protocol for intensivists and pulmonologists to help treat patients with pulmonary arterial hypertension and other chronic lung diseases.
  • Stroke Competency and Update, 01/01/26, Developed a continuing education presentation for all hospital staff to ensure the Health System maintains the title of 'Comprehensive Stroke Center'.
  • Alteplase to Tenecteplase Transition in Acute Ischemic Stroke, 01/01/25, Developed an evidence-based order set to implement within the Health System.
  • Sub-massive Pulmonary Embolism Pathway, 02/01/25, Developed an evidence-based risk stratification and treatment pathway for physicians to treat patients with sub-massive PE.
  • Hypertonic Saline Medical Use Evaluation & Order Set Update, 01/01/24, Presented findings of medical use evaluation (MUE) to physicians and pharmacists of P&T Committee and improved outdated order set based on data findings and updated literature.
  • Aspirin De-Sensitization Protocol, 07/01/22, Developed an evidence-based pathway for pulmonologists to treat patients with Aspirin Exacerbated Respiratory Disease (AERD).
  • Anticoagulant Reversal Guideline Order set, 06/01/22, Developed an evidence-based order set to implement within the Health System.
  • Vasopressin Cost Savings Initiative, 05/01/21, Evaluated Vasopressin dosing within hospital system and provided ways to significantly reduce overall cost burden of medication utilization within Health System.
  • JPS COVID Protocol, 04/01/20, Worked alongside several physician groups to initiate Health System wide practice change by developing an evidence-based protocol to protect patients with COVID19 Pneumonia.
  • Inhaled Aminoglycosides Protocol, 08/01/17, Developed an evidence-based pathway for infectious disease physicians and pulmonologists/intensivists.

Committee Involvement

  • Residency Advisory Committee—Recruitment, JPS Health Network, 07/01/22, present
  • Residency Advisory Committee—Research Chair, JPS Health Network, 07/01/21, 06/30/24
  • EPIC Task Force—Chair, JPS Health Network, 01/01/20, 06/30/24
  • COVID Treatment Protocol Committee, JPS Health Network, 01/01/20, 01/31/22
  • Critical Care Committee, JPS Health Network, 08/01/13, present

Preceptor Experience

  • Texas Tech University School of Health Sciences, 08/01/13, present, Preceptor for IPPE and APPE Students (Intensive Care)
  • University of North Texas School of Health Sciences, 08/01/13, present, Preceptor for IPPE and APPE Students (Intensive Care)
  • John Peter Smith Health Network, 08/01/13, present, Preceptor for PGY-1 Residency, Critical Care Pharmacy
  • University of Florida, College of Pharmacy, 06/01/11, 07/31/13, Preceptor for APPE Students, Critical Care Pharmacy

Awards

  • VIP Award, JPS Health Network, 02/01/26
  • Good Catch Award, JPS Health Network, 12/01/25
  • VIP Award, JPS Health Network, 01/01/25
  • Good Catch Award, JPS Health Network, 08/01/24
  • Good Catch Award, JPS Health Network, 05/01/24
  • Pharmacist of the Month, JPS Health Network, 05/01/24
  • Pharmacist of the Month, JPS Health Network, 01/01/21
  • Award for Excellence - 'Research in Pharmacy Practice', Florida Society of Health System Pharmacists (FSHP), 05/01/12
  • Excellence in Patient Care Award, Roseman University, College of Pharmacy, 06/01/11
  • Nevada Health System Pharmacists (NVSHP) Scholarship, 10/01/10
  • Scholarship for Academic and Professional Merit, 08/01/08, 08/01/09
  • Gold Medals, Osmania University, S.N. Vanitha College of Pharmacy, Ranked first among fourteen hundred students from over twenty colleges of pharmacy throughout the state of Andhra Pradesh, India for four consecutive years., 08/01/04 - 08/01/08

Select Presentations

  • Emergency Medicine Lecture on Management of Severe Agitation, 05/01/26, Didactic lecture given to Emergency Medicine Providers at JPS Health Network.
  • Heads and Hearts Conference—Review of Thrombolytics for Acute Ischemic Stroke, 02/01/25, Presentation to nurses at their annual conference.
  • Emergency Medicine Lecture on Management of Acute Gastrointestinal Bleeding, 06/01/24, Didactic lecture given to Emergency Medicine Providers at JPS Health Network.
  • Opioid Use Disorder in the Intensive Care Unit, 09/01/23, Lecture to physicians, pharmacists and other health care professionals at JPS Health Network and at the Texas Society of Health System Pharmacist Annual Meeting.
  • Fluid Wars in Critical Care: Can We Restore the Balance?, 03/01/22, Journal Club presentation to physicians, pharmacists and other health care professionals at JPS Health Network.
  • Making a Case for the Right -Ase: A Comprehensive Review of Alteplase & Tenecteplase in Pulmonary Embolism and Stroke, 12/01/22, Lecture to physicians, pharmacists and other health care professionals at JPS Health Network.
  • A Comprehensive Review of Adjunctive Agents in treatment of Severe Alcohol Withdrawal, 06/01/21, Presentation at Texas Society of Health System Pharmacist Annual Meeting.
  • A Comprehensive Review of Tocilizumab in COVID-19, 03/01/21, Journal Club presentation to physicians, pharmacists and other health care professionals at JPS Health Network.
  • Peripheral administration of vasopressors, 09/01/19, Journal Club presentation to physicians, pharmacists and other health care professionals at JPS Health Network.
  • OPTALYSE for Pulmonary Embolism Journal Club, 02/01/19, Journal Club presentation to physicians, pharmacists and other health care professionals at JPS Health Network.

Research

  • Reduced Dose vs Weight Based Diltiazem Dosing for Atrial Fibrillation with Rapid Ventricular Response, JPS Health Network, Fort Worth, TX, 2026
  • Leukocytoclastic Vasculitis Associated with COVID-19 Infection: A Case Report, JPS Health Network, Fort Worth, TX, 2024
  • Outcomes Associated with the Discontinuation Order of Norepinephrine and Vasopressin in Resolving Septic Shock, JPS Health Network, Fort Worth, TX, 2020
  • Major publications in Critical Care Pharmacotherapy Literature, Am J Health-Syst Pharm, 2015, 72, e73-84
  • Early Vancomycin De-escalation in Patients with Clinically Suspected Ventilator Associated Pneumonia, 10.1097/01.ccm.0000440332.21697.0f

Timeline

Medical Intensive Care/Pulmonary Clinical Pharmacist

John Peter Smith (JPS) Health Network
2013.08 - Current

Resident Pharmacist

Shands Jacksonville Medical Center
2011.06 - 2013.06

Drug Development Associate

Dr. Reddy Labs
2006.04 - 2006.05

PGY-2 Critical Care Pharmacy Residency -

University of Florida, Shands at Jacksonville Medical Center

PGY-1 Pharmacy Residency -

University of Florida, Shands at Jacksonville Medical Center

Doctor of Pharmacy -

Roseman University of Health Sciences, College of Pharmacy

Bachelor of Pharmacy -

Osmania University
Sloka Manvi